Anna Rubartelli

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 6

Top Topics

Nlrp Inflammasome

Induced Apoptosis

Immune Response

Top Venues

The Journal of biological chemistry

Proceedings of the National Academy of Sciences of the United States of America

Science advances

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Giorgia Careccia, Marielle Saclier, Mario Tirone, Elena Ruggieri, Elisa Principi, Lizzia Raffaghello, Silvia Torchio, Deborah Recchia, Monica Canepari, Andrea Gorzanelli, Michele Ferrara, Patrizia Castellani, Anna Rubartelli, Patrizia Rovere-Querini, Maura Casalgrandi, Alessandro Preti, Isabella Lorenzetti, Claudio Bruno, Roberto Bottinelli, Silvia Brunelli, Previtali Stefano Carlo, Marco Emilio Bianchi, Graziella Messina, Emilie Venereau
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy. Science translational medicine 13 (596) (2021)
Enrica Balza, Sebastiano Carlone, Sonia Carta, Patrizia Piccioli, Vanessa Cossu, Cecilia Marini, Gianmario Sambuceti, Anna Rubartelli, Patrizia Castellani
Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer medicine (2021)
Roberto Sitia, Anna Rubartelli
Evolution, role in inflammation, and redox control of leaderless secretory proteins. The Journal of biological chemistry 295 (22) (2020)
Stefano Bestetti, Iria Medraño-Fernandez, Mauro Galli, Michela Ghitti, Gerd P Bienert, Giovanna Musco, Andrea Orsi, Anna Rubartelli, Roberto Sitia
A persulfidation-based mechanism controls aquaporin-8 conductance. Science advances 4 (5) (2018)
Claudia Semino, Sonia Carta, Marco Gattorno, Roberto Sitia, Anna Rubartelli
Progressive waves of IL-1β release by primary human monocytes via sequential activation of vesicular and gasdermin D-mediated secretory pathways. Cell death & disease 9 (11) (2018)
Carlo Marchetti, Benjamin J Swartzwelter, Fabia Gamboni, Charles P Neff, Katrin Richter, Tania Azam, Sonia Carta, Isak Tengesdal, Travis Nemkov, Angelo D'Alessandro, Curtis Henry, Gerald S Jones, Scott A Goodrich, Joseph P St Laurent, Terry M Jones, Curtis L Scribner, Robert B Barrow, Roy D Altman, Damaris B Skouras, Marco Gattorno, Veronika Grau, Sabina Janciauskiene, Anna Rubartelli, Leo A B Joosten, Charles A Dinarello
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proceedings of the National Academy of Sciences of the United States of America 115 (7) (2018)